A. Langlois et al., FEDOTOZINE BLOCKS HYPERSENSITIVE VISCERAL PAIN IN CONSCIOUS RATS - ACTION AT PERIPHERAL KAPPA-OPIOID RECEPTORS, European journal of pharmacology, 324(2-3), 1997, pp. 211-217
The effect of fedotozine on visceral hypersensitivity was evaluated in
conscious rats. One hour after colonic irritation (0.6% acetic acid i
ntracolonically), a 30 mmHg colonic distension was applied for 10 min.
Irritation increased the number of abdominal contractions induced by
colonic distension (23.4 +/- 4.1 versus 4.8 +/- 1.4 in saline-treated
rats, P < 0.001). Facilitation of colonic pain was reversed in a dose-
dependent manner by fedotozine -1-phenyl-1-[(3,4,5-trimethoxy)benzylox
ymethyl]-N, N-dimethyl-n-propylamine), (+/-)-U-50,488H l-N-(2-[1-pyrro
lidinyl]cyclohexyl)benzeneacetamide and morphine (respective ED50 valu
es 0.67, 0.51 and 0.23 mg/kg s.c.). The kappa-opioid receptor antagoni
st, nor-binaltorphimine, abolished the effects of fedotozine and (+/-)
-U-50,488H but not those of morphine. Low doses of naloxone (30 mu g/k
g s.c.) blocked the effect of morphine but not of fedotozine or (+/-)-
U-50,488H. After intracerebroventricular administration, morphine was
very potent (ED50 1.7 mu g/rat), (+/-)-U-50,488H poorly active (58% of
antinociception at 300 mu g/rat) and fedotozine inactive up to 300 mu
g/rat. These results show that fedotozine blocks hypersensitive visce
ral pain by acting on peripheral kappa-opioid receptors in animals. (C
) 1997 Elsevier Science B.V.